Please use this identifier to cite or link to this item:
Title: Methodological Issues of using Placebos in Interventions Based on Digital Technology
Authors: Farr, W
Male, I
Green, D
Morris, C
Gage, H
Bailey, S
Speller, S
Colville, V
Jackson, M
Bremner, S
Memon, A
Issue Date: 8-Sep-2017
Publisher: JMTM
Citation: Journal of Mobile Technology in Medicine, 2017, 6 (2), pp. 56 - 63
Abstract: Background/Aims: Use of placebo is the ideal for comparison in clinical trials to reduce biases. With digital technology being used more frequently in healthcare interventions, how do we determine the placebo effect where interventions exploit technology? If placebo in medicine is traditionally defined by a lack of pharmacological agents, how might we begin to move towards controlling for effects of digital technology? Method: This paper explores the traditional placebo effect and discusses its impact in healthcare contexts with digital technology with reference to a particular trial. Different meanings of placebo in the context of evaluating technology suggest new challenges and positive consequences. Results: Methodological considerations are discussed, which enabled the development of a placebocontrolled evaluation of a digital technology in healthcare and rehabilitation. Conclusion: Digital placebo was controlled in our trial by employing technology across all groups in the absence of evidence-based practice and shows how to control for unknown and hidden effects of technology.
Appears in Collections:Dept of Clinical Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf517.8 kBAdobe PDFView/Open

Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.